HPTN 074

Status:Completed
Phase:Open Label, III
Principal Investigator(s):William Miller
Objective:The purpose of this study is to determine the feasibility of a future trial that will assess whether an integrated intervention combining psychosocial counseling and supported referrals for antiretroviral therapy (ART) at any CD4 cell count and substance use treatment for HIV-infected people who inject drugs (PWID) will reduce HIV transmission to HIV-uninfected injection partners, as compared to routine care dictated by national guidelines for HIV-infected PWID.Last updated June 10, 2022
Prevention Option(s):PrEP, Treatment U=U
Study Design:Open label, Randomized
Results: A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment
Official Code: NCT02935296
Related Publications:
Phylogenetic Analysis of Human Immunodeficiency Virus from People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074
Trial Sponsors: HPTN, NIAID, NIDA
Start Date
End Date
February 1, 2015
June 30, 2018
Enrollment:1,281
Age range: 18 Years ↔ 45 Years
Population:Injecting drug users, People Living with HIV